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Studies of the urine-based point-of-contact cathodic circulating antigen test (POC-CCA) in
Schistosoma mansoni -endemic settings in Africa indicate it has good sensitivity in detect-
ing infections, but in areas of low prevalence, the POC-CCA can be positive for persons
who are egg-negative by Kato-Katz stool assays. We examined the POC-CCA assay for: (a)
batch-to-batch stability; (b) intra-reader and inter-reader variability; (c) day-to-day variability
compared to Kato-Katz stool assays, and (d) to see if praziquantel (PZQ) treatment con-
verted Kato-Katz-negative/POC-CCA positive individuals to POC-CCA negativity. We found
essentially no batch-to-batch variation, negligible intra-reader variability (2%), and substan-
tial agreement for inter-reader reliability. Some day-to-day variation was observed over
5 days of urine collection, but less than the variation in Kato-Katz stool assays over 3 days.
To evaluate the effect of treatment on Kato-Katz(−)/POC-CCA(+) children, 149 children in
an area of 10–15% prevalence who were Kato-Katz(−) based on 3 stool samples but POC-
CCA(+) were enrolled. Seven days after treatment (PZQ 40 mg/kg) samples were again
collected and tested. Almost half (47%) POC-CCA positive children turned negative.Those
still POC-CCA positive received a second treatment, and 34% of them turned POC-CCA
negative upon this second treatment. Most who remained POC-CCA positive shifted each
time to a “lesser” POC-CCA “level of positivity.” The data suggest that most Kato-Katz-
negative/POC-CCA positive individuals harbor low-intensity infections, and each treatment
kills all or some of their adult worms.The data also suggest that when evaluated by a more
sensitive assay, the effective cure rates for PZQ are significantly less than those inferred
from fecal testing. These findings have public health significance for the mapping and
monitoring of Schistosoma infections and in planning the transition from schistosomiasis
morbidity control to elimination of transmission.
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INTRODUCTION
WHO guidelines for control and elimination of schistosomiasis
involve pre-treatment and periodic post-treatment evaluations of
the prevalence of Schistosoma infections to inform programmatic
decisions on whom, and how often to treat within endemic areas
(1). For Schistosomamansoni, this has usually involved mapping by
examinations for parasite eggs in the stool, most often by the Kato-
Katz thick-smear microscopic technique (2). By making stool
exams more feasible on a population level, the Kato-Katz technique
revolutionized the process of obtaining intensity and prevalence
data from large numbers of people. This assay worked very well
for control programs in areas of high intensity and corresponding
high prevalence. It was used extensively and became established
as part of WHO guidelines for morbidity control programs, with
prevalence estimates usually based on examination of one stool
per subject, using two separate Kato-Katz slides. In situations with
high-mean intensities of infection (and of corresponding high
prevalence), the Kato-Katz is believed to provide close to true
prevalence estimates of local infection for schistosomiasis con-
trol programs (3). Research programs also use it extensively – most
often testing three consecutive stools, two Kato-Katz slides on each
stool for greater accuracy of diagnosis. However, the Kato-Katz
assay has documented day-to-day and intra-stool variability, espe-
cially in communities with moderate-to-low intensity of infection
and corresponding low prevalence. Day-to-day variation is bio-
logical (4), and intra-stool variation is related to sampling error
based on the amount of stool evaluated (5). Thus, the Kato-Katz
test is acknowledged to be relatively insensitive at lower levels of
intensity of infection, often corresponding to lower prevalence as
well. Over the course of a control program, the ability of the Kato-
Katz assay to provide true prevalence estimates will become less
and less as the population mean intensity of infection decreases
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(6–14). Over 20 years ago, de Vlas et al. (3, 15, 16) published a series
of statistical reviews that showed that programmatic dependence
on a single stool examination led to underestimates of true preva-
lence and that observations based on such surveys could result in
inaccurate allocation of control measures.
Currently, an ideal diagnostic tool for implementing schistoso-
miasis control programs would be one that could be easily used
for regional mapping to initiate a “gaining control” program. In
this scenario, low sensitivity may be acceptable but high specificity
is good. A tool for monitoring the post-treatment impact of an
initial “gaining” or ongoing “sustaining” control program would
need to have high sensitivity for low intensity infections and retain
high specificity. It would serve as the tool that determines if it is
time to switch MDA protocols or add adjunct strategies, such as
snail control, behavioral change, or implementation of water and
sanitation measures, as prevalence and intensities decrease. The
tool used to determine when it is time to switch from a standard
control program to a more aggressive elimination program must
have very high sensitivity, and ideally high specificity too. A post-
elimination surveillance tool would require excellent sensitivity
and excellent specificity based on exposure or infection and allow
high throughput.
Over the last several years, multiple studies have evaluated a
commercially available, urine-based, point-of-contact (POC) cas-
sette assay that detects circulating cathodic antigen (CCA). CCA
is derived from the gut of adult schistosomes that are established
in the human circulation (8, 17–22). The antigen is eliminated by
the kidneys into the urine where it can be detected by a standard-
ized immunoassay. In general, the results of earlier evaluations
indicate that the POC-CCA assay is suitable for the prevalence
mapping required for regional schistosomiasis morbidity control
programs (21). For this purpose, POC-CCA testing appears just as
good as or better than using Kato/Katz assays. With the additional
advantage of being urine-based, it is able to be done on-site, and
appears to be more sensitive for detection of S. mansoni infec-
tion at low egg intensities (8, 21, 22). The POC-CCA is now
being used in several countries, but its performance should be
continually reassessed to determine its potential flaws and limi-
tations as control programs mature. Because there is no sensitive
and specific “gold standard” for diagnosis of active S. mansoni
infection, there remain questions about the overall specificity and
sensitivity of the POC-CCA assay and thus about its use in place
of the Kato-Katz assay for programmatic decision making. One
of the questions revolves around observer readings of faint diag-
nostic bands, considered positive by the manufacturer and called
“trace” results. However, it has also been suggested that infor-
mation can be obtained based on the differential intensity of a
positive POC-CCA band to indicate, in semi-quantitative fash-
ion, levels of intensity of infection (13, 21, 23). In addition, it
is questioned if the POC-CCA assay could prove more reliable
than the Kato-Katz as an indicator of the effectiveness of drug
treatment of S. mansoni infections (23). In the present report, we
address some of these questions based on prospective laboratory
and field trials in an S. mansoni-endemic area of Kenya, on addi-
tional testing data from a non-endemic site in coastal Ecuador,
and previously reported data (21) from a non-endemic area of
Ethiopia.
MATERIALS AND METHODS
ETHICS STATEMENT AND PARTICIPANT SELECTION
The study protocol was approved by the scientific steering commit-
tee (SSC) of the Kenya Medical Research Institute (KEMRI, SSC
number 1820), the Ethical Review Committee (ERC) of KEMRI,
the Institutional Review Boards (IRB) of the Centers for Dis-
ease Control and Prevention (CDC), the Pontificia Universidad
Catolica del Ecuador, Quito, Ecuador, the Aklilu Lemma Insti-
tute of Pathobiology, Addis Ababa University of Ethiopia and
of the University of Georgia. Parents/guardians, and participat-
ing children were informed about the purpose and procedures
of the study. Written informed consent was obtained from the
parents/guardians and the children participating in the study gave
assent prior to study enrollment. All samples obtained in the study
were coded and treated confidentially.
STUDY POPULATION AND SAMPLE COLLECTION
Most of this study was conducted in schools near the shores of
Lake Victoria, western Kenya from January 2013 to April 2014.
Studies in areas known not to be endemic for schistosomiasis
but endemic for soil-transmitted helminths (STHs) were done in
Ethiopia [as previously reported; (21)], and in the coastal region
of Ecuador. From each school, children above the age of 6 years
for whom consent and assent had been obtained were selected for
study inclusion. All children who were positive for schistosome
infection were treated with praziquantel (PZQ) (40 mg/kg) and
children positive for STHs were given 400 mg Albendazole as a
single dose. All contact with the children was done at the school.
LABORATORY METHODS AND STUDY DESIGNS
Kato-Katz testing
Stool samples collected were processed within 24 h of collection
using the Kato-Katz thick-smear technique in duplicate (normally
three stools, six slides) for the quantitative determination of S.
mansoni and STHs (2). Each slide was read within 1 h of prepara-
tion to diagnose presence of hookworm,Ascaris lumbricoides, and
Trichuris trichiura by two well-trained microscopists. The S. man-
soni readings were performed at least 24 h after slide preparation
and recorded as number of eggs per gram of stool (EPG) (2). The
results of all slides read were averaged and the intensity of infection
classified according to the WHO guidelines (24). STH infections
were simply categorized as being either positive or negative.
POC-CCA testing
Urine samples were collected and tested in the laboratory for posi-
tivity and band intensity by the commercially available POC-CCA
assay, according to manufacturer’s instructions (Rapid Diagnos-
tics, Pretoria). Briefly, one drop of urine was added to the well of
the testing cassette and allowed to absorb. Once it was absorbed, a
drop of buffer (included in the kit) was added into the same well
and the assay was allowed to develop for 20 min, at which time the
results were read. The tests were considered invalid if an internal
control band did not appear or if the tests were left to develop for
more than 25 min after addition of the buffer before being read.
In these few cases, the samples were re-run with a new test cassette
and scored appropriately. To score the intensity of the POC-CCA
assay results, the intensity of the test band was compared to that
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of the control band. Positive results were given a score of “trace”
if the band was barely visible, 1+ if the test band was less intense
than the control band, 2+ if the test band was of equal intensity as
the control band, and 3+ if the test band was more intense than
the control band.
Cassette batch variation
Five separate batches of CCA test kits were used for this study.
Three readers were provided with 10 urine samples from subjects
who either did not have S. mansoni infections or had infections
that ranged from low to moderate intensity based on Kato-Katz
stool examinations. Each of the 3 readers read the 10 urine sam-
ples using 10 POC-CCA cassettes from Box # 1. The urine samples
were shuffled and then read again using 10 cassettes from Box # 2;
this retesting of the 10 test urines continued using cassettes from
the remaining boxes, 10 per box, to Box # 5.
Intra-reader reliability
Five readers were provided with 10 urines that ranged from neg-
ative to moderately positive, as described above. In Round 1,
each reader read urine results using 10 individual POC-CCA
cassettes read at 20 min. For Round 2, the cassettes were ran-
domly rearranged, and each reader re-read and re-scored the same
(masked) cassettes for a second time within ~5 min, to keep within
the time limit for valid cassette readings.
Inter-observer reliability
Five readers were provided with 30 urines that ranged from nega-
tive to moderately positive, as described above. The five readers
read the urines on POC-CCA cassettes independently and the
results were recorded without discussion.
Day-to-day variability
Seventy-three participants were recruited for this study. Five con-
secutive urine samples for POC-CCA and three consecutive stool
samples for Kato-Katz were collected and assessed to determine if
there were any fluctuations in the POC-CCA or Kato-Katz readings
based on the different days of collection.
Post-treatment readings and re-treatments
One hundred forty-nine children from schools that had received
two or three rounds of annual MDA with PZQ and who were
POC-CCA positive but Kato-Katz negative (based on a single urine
sample and three stool samples) were enrolled at baseline, and
treated with PZQ based on the POC-CCA positive results. Seven
days later, a single urine and stool sample were collected and tested
by POC-CCA and Kato-Katz, respectively. Children who were still
POC-CCA positive were treated for a second time, and 7 days later
urine and stool samples were again collected and assayed. Chil-
dren who were still POC-CCA positive were again treated for a
third time without further testing. A schematic diagram of the
post-treatment study is shown in Figure 1.
DATA ANALYSES
Data collected from evaluations of school children included egg
intensity readings and POC-CCA cassette band readings and were
entered into an Excel database and analyzed using SAS statistical
software (SAS,Cary,NC,USA). Fleiss kappa statistical analysis (25)
FIGURE 1 | Flow diagram of post-praziquantel treatment study, Kenya.
was used to measure the level of inter-reader agreement among five
readers, with values of 0.00–0.20 considered slight, 0.21–0.40 fair,
0.41–0.60 moderate, 0.61–0.80 substantial, and 0.81–1.00 almost
perfect agreement (26). The estimated diagnostic accuracy of
the Kato-Katz and POC-CCA tests was compared using Bayesian
latent class modeling software (27), or by measuring detection
accuracy against a “combined gold standard.” The combined gold
standard was defined as any one positive test out of all eight tests
(five consecutive CCA and three Kato/Katz tests) for any indi-
vidual subject. In a separate analysis, Spearman’s rank correlation
was used to compare trace, 1+, 2+, 3+ band intensity on the
POC-CCA assay with estimated infection intensity determined
by Kato-Katz egg counts. Fleiss kappa and Spearman’s rho were
analyzed using IBM SPSS 21.
RESULTS
CASSETTE BATCH VARIATION
When different batches of the cassettes provided by the manu-
facturer were tested on the same 10 urine samples, there was no
real variation between them. Nine of 10 samples showed the same
results across all 5 batches for all 3 readers. Only one sample gave
varying results when cassettes were taken from different batches,
being negative for some lots and trace (positive) on others. This
same variation occurred for all three readers.
INTRA-READER RELIABILITY
When 5 trained readers read two rounds of the same 10 specimens,
there was only 1 reading of the 50 pairs of repeat readings that was
not replicated. That one was read as negative the first time and
as trace (positive) when it was re-read by one of the readers. This
corresponds to a 2% intra-reader variation.
INTER-READER RELIABILITY
When 5 trained readers were evaluated in regard to the reliabil-
ity of their readings of the same 30 specimens and the results
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analyzed by Fleiss kappa statistics the overall Fleiss kappa value
for inter-reader agreement of the POC-CCA scores was 0.70 (95%
confidence interval: 0.58, 0.81;P < 001). This indicates substantial
agreement between the five different readers.
DAY-TO-DAY VARIABILITY
Seventy-three participants each had POC-CCA tests on five con-
secutive days’urines; and Kato-Katz tests on three consecutive days’
stools (two slides each) to evaluate S. mansoni prevalence. This
study sample was representative of a moderate-to-high prevalence
area (44% on the first Kato-Katz stool/two slides). As per the man-
ufacturer’s instructions,“Trace”readings were considered positive.
For each assay, prevalence estimates based on single tests did not
vary significantly between days, ranging between 81 and 88% for
the five consecutive POC-CCA and between 41 and 44% for three
consecutive Kato/Katz tests. Almost all (94%) of children were
positive for at least one of the five POC-CCA tests while 70% were
positive for the at least one of Kato/Katz tests (Table 1).
When the first three CCA consecutive tests were taken together,
82% of participants had consistent daily results compared to only
49% of participants with consistent daily results by Kato-Katz
assays. Mixed results (i.e., both positive and negative results for
the same participant) were observed in 18% of the participants
for the POC-CCA tests but in 48% of Kato-Katz tests. Thus, while
there was some day-to-day variation for both assays, the Kato-Katz
varied much more in terms of diagnosing the presence of infection
than the POC-CCA (Table 2).
The sensitivity and specificity of the POC-CCA assay were eval-
uated against an artificial “gold standard” of any one positive test
of the combined eight tests (five POC-CCA and three Kato-Katz).
These analyses indicated that the POC-CCA assay provided high
levels of both sensitivity and specificity, as shown in Table 3.
When the POC-CCA assay was tested in areas in Ethiopia and
Ecuador that had never been endemic for schistosomiasis but were
endemic for STH, only one presumably false positive test was
found among 100 participants in Ethiopia (21), while none in
the 143 participants from Ecuador was positive.
A Bayesian latent class model (BLCM) was developed using
data from all 73 subjects in this part of the study, assessing the
Table 1 | Schistosomiasis prevalence based on one or several
POC-CCA and Kato-Katz tests among 73 school children, Kenya.
Prevalence, N (%)
POC-CCA





At least 1 of 5 CCA tests positive 69 (94)
Kato-Katz
Day 1 32 (44)
2 31 (43)
3 30 (41)
At least 1 of 3 K-K tests positive 51 (70)
most likely performance characteristics of 1 up to 5 daily POC-
CCA results, and 1 up to 3 daily Kato-Katz stool results, guided by
the POC-CCA specificity data Ethiopian and Ecuadorian children
described above (Figure 2). By this analysis, it was estimated that
the sensitivity of a single POC-CCA assay was likely to be much
greater than that of a single Kato-Katz test, and even more sensi-
tive than performing three Kato-Katz tests in detecting S. mansoni
infection in the study population. The estimated specificity for
both POC-CCA and Kato-Katz assays approached 100%.
Infection intensity using POC-CCA can be determined only
semi-quantitatively by comparing the density of the test line that
develops to the control line provided in the cassette. Yet, we found
a good correlation between egg intensity determined by Kato-Katz
as compared to POC-CCA scores based on readings the intensities
of the positive bands. All the 10 participants who had moderate
or high egg counts by Kato-Katz had an unambiguously positive
PCO-CCA result. There was a significant correlation between a
participant’s mean EPG and their CCA score on all of the tested
days (Figure 3).
POST-TREATMENT READINGS AND RE-TREATMENTS
For this phase of the study, 149 children who had tested negative
by Kato-Katz (3 stools/2 slides each) but positive by POC-CCA
(tested on a single urine) were selected from an area that had
achieved 10–15% overall S. mansoni prevalence (by Kato-Katz)
following 2 or 3 rounds of MDA with PZQ. One week after test-
ing, 126 of these children were treated with PZQ. Of those not
lost to follow-up, 55 of 117 (47%) became POC-CCA negative
on repeat testing performed 1 week post-treatment. Those who
remained POC-CCA positive (and were available) were treated a
second time, and 7 days later, 19 of 56 (34%) children were negative
Table 2 | Consistency of results for three consecutive diagnostic tests
for schistosomiasis on 73 school children, Kenya.
N (%)
Result of 3 POC-CCA tests
All 3 negative 5 (7)
All 3 positive (Trace/1/2/3) 55 (75)
Mixed positive and negative results 13 (18)
Result of 3 Kato-Katz tests (2 slides taken together)
All 3 negative 21 (29)
All 3 positive 15 (20)
Mixed positive and negative results 35 (48)
Table 3 | Sensitivity and specificity analysis of POC-CCA one day
testing evaluated against a combined gold standard of at least 1 of 8
tests (5 POC-CCA and 3 Kato-Katz) being positive.
Sensitivity, % (95% CI) Specificity, % (95% CI)
CCA day 1 85.5 (74.9–2.8) 100 (40.2–100)
CCA day 2 89.9 (80.2–95.8) 100 (40.2–100)
CCA day 3 89.9 (80.2–95.8) 100 (40.2–100)
CCA day 4 89.9 (80.2–95.8) 100 (40.2–100)
CCA day 5 92.7 (83.9–97.6) 100 (40.2–100)
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FIGURE 2 | Bayesian latent class modeling values for sensitivity and specificity of single and multiple POC-CCA tests versus one or more Kato-Katz
tests, Kenya.
FIGURE 3 | Correlation between intensity of infection by Kato-Katz
(EPG) and band intensity by POC-CCA. Representative boxplot is shown
from day 5 POC-CCA test. There is a significant association between the
EPG and CCA band intensity: Spearman’s rho=0.601 (P <0.001).
based on follow-up POC-CCA testing at that time. The Kato-Katz
assays of these children, who were selected as Kato-Katz negative,
remained negative after each treatment round.
DISCUSSION
Many schistosomiasis control programs in Sub-Saharan Africa are
now at the point of mapping and moving toward gaining control
by mass drug administration. Some are sustaining control at a
moderate level but will eventually wish to move toward elimi-
nation of transmission of S. mansoni infection. The sensitivity
of the assay used to evaluate prevalence in these different phases
becomes critical, as the current Kato-Katz test is known to become
significantly less sensitive as egg count intensities decrease (23,
24, 28–33). Our data and those from other studies indicate that
the POC-CCA assay is more sensitive than the Kato-Katz assay
(13, 22). Therefore, in moderate to lower prevalence and inten-
sity areas, POC-CCA will indicate higher prevalence levels than
the Kato-Katz. Since prevalence estimates impact programmatic
guidelines for coverage, questions have been raised about the true
sensitivity and specificity of POC-CCA readings. For this reason,
we undertook further evaluation of this urine-based,commercially
available assay.
Our study found little or no variability of performance between
batches of the POC-CCA cassettes, and intra-reader variability
was minimal when trained technicians performed the assay. In
addition, Fleiss kappa statistics indicated substantial agreement in
regard to inter-reader reliability among 5 trained readers read-
ing 30 specimens (Fleiss kappa value= 0.70). We had previously
observed that when non-technician field workers were minimally
trained and then asked to read multiple POC-CCA tests, there
was considerable variation in the readings. Since there was little or
no variability seen when trained readers (laboratory technicians)
were used, this highlights the need for adequate training prior to
use of the POC-CCA assay.
Day-to-day variability in per-subject prevalence, based on read-
ings from 3 successive days of Kato-Katz or 5 days of POC-CCA,
was minimal and almost all variation occurred at the very low
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intensity end of the CCA test spectrum, involving “trace” read-
ings. Also, based on the first 3 days of testing run in parallel, the
day-to-day variability of the POC-CCA readings (18%) was much
less than those of the Kato-Katz (48%).
Our post-treatment data suggest that, based on the esti-
mated sensitivity of the POC-CCA assay, many of the Kato-Katz-
negative/POC-CCA positive results reflect continued infection,
i.e., these subjects have remaining worms that continue to make
detectable levels of CCA. This means that currently accepted PZQ
cure rates for Schistosoma infection are likely to be significantly
overestimated, based on the post-treatment inaccuracy of a lower-
sensitivity assay, the Kato-Katz. PZQ is typically said to produce
70–90% cure rates as evaluated by Kato-Katz assays (34–37). If,
in fact, many treated individuals continue to harbor low–intensity
infection (as determined by a more sensitive assay such as the
POC-CCA) this suggests the need to treat many more people,
more often, for persistent infection. Such a shift in recommen-
dations would constitute a significant alteration in programmatic
decision-making algorithms from when Kato-Katz testing is used
as the sole diagnostic criterion.
Our data and those of others (13) indicate that the POC-CCA
assay can be used in post-treatment studies and programs, and
is indeed more suitable for post-treatment evaluations where the
goal is to detect uncured persons. In an earlier drug efficacy study,
the POC-CCA was found to be more sensitive than six Kato-Katz
slides (two/slides on three stools) at 4-weeks-post-praziquantel,
and again at 6 months post-praziquantel (13). We have shown
that, following treatment, there are still those with positive POC-
CCA readings who are K-K negative – and these drop by roughly
half upon a second treatment and again after another retreatment.
Those who do not convert to POC-CCA negative upon these
treatments decreased the intensity of their CCA bands, perhaps
indicating successive partial cures (Figure 4).
Locations that were endemic for STH but not human schisto-
somes (areas of Ethiopian and Ecuador) yielded only one “trace”
POC-CCA positive (from Ethiopia) child out of 243 children
tested, confirming the high specificity of this assay.
In conclusion, our data show that most (if not all) Kato-Katz-
negative/POC-CCA positive individuals in endemic areas are likely
to harbor low level infections with S. mansoni. While not a per-
fect test (as seen in the day-to-day variability) the POC-CCA assay
appears to be highly suitable for initial mapping of S. mansoni
areas, and for subsequent post-treatment programmatic decision
making. The fact that it indicates higher prevalences than the less
sensitive Kato-Katz in areas with low-average intensity should now
be factored into how treatment decisions will be made. Our data
bring up the possibility that many people in endemic areas are
harboring low levels of worms that are producing few, if any, eggs
on a daily basis. This raises an issue that is seldom voiced, but may
be quite important in programmatic thinking. What are the con-
sequences of such a scenario? If few or no eggs are being released
every day, does that level of infection still lead to morbidity? If few
or no eggs are being released, it would seem that the implications
for transmission would be important. We do not yet have answers
to these questions, but believe they need to be discussed. They will
continue to arise as the POC-CCA and other more sensitive assays
are introduced and employed more widely in the field.
FIGURE 4 | POC-CCA results following two rounds of praziquantel
treatment, Kenya.
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